Gene · 1673
Papers4,248
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 4,248
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Antimicrobial skin peptides in premature infants: Comparison with term infants and impact of perinatal factors. | Front Immunol | 2023 | 36923410 | PubTator, text mining | PubMed |
| Exploring the structural basis to develop efficient multi-epitope vaccines displaying interaction with HLA and TAP and TLR3 molecules to prevent NIPAH infection, a global threat to human health. | PLoS One | 2023 | 36920996 | PubTator, text mining | PubMed |
| Infant Feeding, Gut Permeability, and Gut Inflammation Markers. | J Pediatr Gastroenterol Nutr | 2023 | 36913717 | PubTator, text mining | PubMed |
| Th2 Cytokines Affect the Innate Immune Barrier without Impairing the Physical Barrier in a 3D Model of Normal Human Skin. | J Clin Med | 2023 | 36902728 | PubTator, text mining | PubMed |
| Macrophage Biology in Human Granulomatous Skin Inflammation. | Int J Mol Sci | 2023 | 36902053 | PubTator, text mining | PubMed |
| Vitamin D as a Shield against Aging. | Int J Mol Sci | 2023 | 36901976 | PubTator, text mining | PubMed |
| The Challenge of Periprosthetic Joint Infection Diagnosis: From Current Methods to Emerging Biomarkers. | Int J Mol Sci | 2023 | 36901750 | PubTator, text mining | PubMed |
| The Epidermal Keratinocyte as a Therapeutic Target for Management of Diabetic Wounds. | Int J Mol Sci | 2023 | 36901720 | PubTator, text mining | PubMed |
| From PROTAC to inhibitor: Structure-guided discovery of potent and orally bioavailable BET inhibitors. | Eur J Med Chem | 2023 | 36898329 | PubTator, text mining | PubMed |
| Macrophages immunomodulation induced by Porphyromonas gingivalis and oral antimicrobial peptides. | Odontology | 2023 | 36897441 | PubTator, text mining | PubMed |
| The TIMELESS effort for timely DNA replication and protection. | Cell Mol Life Sci | 2023 | 36892674 | PubTator, text mining | PubMed |
| Management of Infections in Psoriatic Patients Treated with Systemic Therapies: A Lesson from the Immunopathogenesis of Psoriasis. | Dermatol Pract Concept | 2023 | 36892377 | PubTator, text mining | PubMed |
| Commentary: Transcriptome analysis of host inflammatory responses to the ectoparasitic mite Sarcoptes scabiei var. hominis. | Front Immunol | 2023 | 36875118 | PubTator, text mining | PubMed |
| Loss of p53 activates thyroid hormone via type 2 deiodinase and enhances DNA damage. | Nat Commun | 2023 | 36871014 | PubTator, text mining | PubMed |
| [Features of innate immunity indicators in patients with recurrent exudative otitis media]. | Vestn Otorinolaringol | 2023 | 36867137 | PubTator, text mining | PubMed |
| Crocodile defensin (CpoBD13) antifungal activity via pH-dependent phospholipid targeting and membrane disruption. | Nat Commun | 2023 | 36859344 | PubTator, text mining | PubMed |
| Spatial Positioning of Immune Hotspots Reflects the Interplay between B and T Cells in Lung Squamous Cell Carcinoma. | Cancer Res | 2023 | 36853169 | PubTator, text mining | PubMed |
| Secreted Aspartyl Proteinases Targeted Multi-Epitope Vaccine Design for Candida dubliniensis Using Immunoinformatics. | Vaccines (Basel) | 2023 | 36851241 | PubTator, text mining | PubMed |
| Targeted Protein-Specific Multi-Epitope-Based Vaccine Designing against Human Cytomegalovirus by Using Immunoinformatics Approaches. | Vaccines (Basel) | 2023 | 36851082 | PubTator, text mining | PubMed |
| Photonics-based treatments: Mechanisms and applications in oral infectious diseases. | Front Microbiol | 2023 | 36846804 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1673/papers?page=23